These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 25339605)

  • 41. Thromboprophylaxis patterns, risk factors, and outcomes of care in the medically ill patient population.
    Mahan CE; Fisher MD; Mills RM; Fields LE; Stephenson JJ; Fu AC; Spyropoulos AC
    Thromb Res; 2013 Nov; 132(5):520-6. PubMed ID: 24080150
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk factors for venous thromboembolism during pregnancy.
    Jensen TB; Gerds TA; Grøn R; Bretler DM; Schmiegelow MD; Andersson C; Azimi A; Gislason G; Torp-Pedersen C; Olesen JB
    Pharmacoepidemiol Drug Saf; 2013 Dec; 22(12):1283-91. PubMed ID: 24130063
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study.
    Mahmoodi BK; ten Kate MK; Waanders F; Veeger NJ; Brouwer JL; Vogt L; Navis G; van der Meer J
    Circulation; 2008 Jan; 117(2):224-30. PubMed ID: 18158362
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States.
    Khorana AA; Dalal M; Lin J; Connolly GC
    Cancer; 2013 Feb; 119(3):648-55. PubMed ID: 22893596
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Incidence of venous thromboembolism in patients with ovarian cancer undergoing platinum/paclitaxel-containing first-line chemotherapy: an exploratory analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group.
    Fotopoulou C; duBois A; Karavas AN; Trappe R; Aminossadati B; Schmalfeldt B; Pfisterer J; Sehouli J;
    J Clin Oncol; 2008 Jun; 26(16):2683-9. PubMed ID: 18509180
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia.
    Thol F; Damm F; Lüdeking A; Winschel C; Wagner K; Morgan M; Yun H; Göhring G; Schlegelberger B; Hoelzer D; Lübbert M; Kanz L; Fiedler W; Kirchner H; Heil G; Krauter J; Ganser A; Heuser M
    J Clin Oncol; 2011 Jul; 29(21):2889-96. PubMed ID: 21670448
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The outcome of allogeneic HSCT in older AML patients is determined by disease biology and not by the donor type: an analysis of 96 allografted AML patients ≥ 50 years from the Czech acute leukaemia clinical register (alert).
    Jindra P; Muzik J; Indrak K; Zak P; Sabty FA; Kozak T; Cetkovsky P; Karas VK; Raida L; Szotkowski T
    Neoplasma; 2013; 60(5):576-83. PubMed ID: 23790178
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Long-term survival results according to cytogenetic risk in patients with acute myeloid leukemia--singl center experience].
    Piatkowska-Jakubas B; Mensah-Glanowska P; Salamańczuk Z; Skotnicki AB
    Przegl Lek; 2011; 68(6):291-5. PubMed ID: 22039664
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic significance of CEBPA mutations in a large cohort of younger adult patients with acute myeloid leukemia: impact of double CEBPA mutations and the interaction with FLT3 and NPM1 mutations.
    Green CL; Koo KK; Hills RK; Burnett AK; Linch DC; Gale RE
    J Clin Oncol; 2010 Jun; 28(16):2739-47. PubMed ID: 20439648
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival.
    Ku GH; White RH; Chew HK; Harvey DJ; Zhou H; Wun T
    Blood; 2009 Apr; 113(17):3911-7. PubMed ID: 19088376
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Incidence of venous thromboembolism and the impact on survival in breast cancer patients.
    Chew HK; Wun T; Harvey DJ; Zhou H; White RH
    J Clin Oncol; 2007 Jan; 25(1):70-6. PubMed ID: 17194906
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cytogenetic clonal heterogeneity is not an independent prognosis factor in 15-60-year-old AML patients: results on 1291 patients included in the EORTC/GIMEMA AML-10 and AML-12 trials.
    Baron F; Stevens-Kroef M; Kicinski M; Meloni G; Muus P; Marie JP; Halkes CJM; Thomas X; Vrhovac R; Specchia G; Lefrere F; Sica S; Mancini M; Venditti A; Hagemeijer A; Becker H; Jansen JH; Amadori S; de Witte T; Willemze R; Suciu S
    Ann Hematol; 2018 Oct; 97(10):1785-1795. PubMed ID: 29926156
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prediction of postdischarge venous thromboembolism using a risk assessment model.
    Iannuzzi JC; Young KC; Kim MJ; Gillespie DL; Monson JR; Fleming FJ
    J Vasc Surg; 2013 Oct; 58(4):1014-20.e1. PubMed ID: 23683384
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Time-dependent risk and predictors of venous thromboembolism in breast cancer patients: A population-based cohort study.
    Brand JS; Hedayati E; Bhoo-Pathy N; Bergh J; Hall P; Humphreys K; Ludvigsson JF; Czene K
    Cancer; 2017 Feb; 123(3):468-475. PubMed ID: 27727456
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multicentre validation of the Geneva Risk Score for hospitalised medical patients at risk of venous thromboembolism. Explicit ASsessment of Thromboembolic RIsk and Prophylaxis for Medical PATients in SwitzErland (ESTIMATE).
    Nendaz M; Spirk D; Kucher N; Aujesky D; Hayoz D; Beer JH; Husmann M; Frauchiger B; Korte W; Wuillemin WA; Jäger K; Righini M; Bounameaux H
    Thromb Haemost; 2014 Mar; 111(3):531-8. PubMed ID: 24226257
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Venous thromboembolism in chronic lymphocytic leukemia: a Danish nationwide cohort study.
    Gade IL; Riddersholm SJ; Christiansen I; Rewes A; Frederiksen M; Enggaard L; Poulsen CB; Bergmann OJ; Gillström DB; Pedersen RS; Nielsen L; Eriksen HH; Torp-Pedersen C; Kristensen SR; Severinsen MT
    Blood Adv; 2018 Nov; 2(21):3025-3034. PubMed ID: 30425066
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-Term Effects of Unprovoked Venous Thromboembolism on Mortality and Major Cardiovascular Events.
    Chang WT; Chang CL; Ho CH; Hong CS; Wang JJ; Chen ZC
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28468786
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Significance of venous thromboembolism in women with cervical cancer.
    Matsuo K; Moeini A; Machida H; Fullerton ME; Shabalova A; Brunette LL; Roman LD
    Gynecol Oncol; 2016 Sep; 142(3):405-12. PubMed ID: 27350404
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of Nonalcoholic Fatty Liver Disease and Venous Thromboembolism in Women With Endometrial Cancer.
    Moeini A; Machida H; Takiuchi T; Blake EA; Hom MS; Miki T; Matsuo O; Matsuo K
    Clin Appl Thromb Hemost; 2017 Nov; 23(8):1018-1027. PubMed ID: 27582024
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effect of chronic liver disease on venous thromboembolism among medically managed patients in Singapore General Hospital.
    Yang Y; Zhang XZ; Ng HS; Fong JC; Lee LH
    Thromb Res; 2015 Sep; 136(3):548-51. PubMed ID: 26164397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.